Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs.
While ethanol is primarily metabolized to acetaldehyde and acetic acid via alcohol dehydrogenase, a minor but increasingly important pathway in the field of forensic science involves the conjugation of glucuronic acid to form an ethyl glucuronide (EtG) metabolite. The kinetics of ethyl glucuronide formation were examined in human liver microsomes (HLM) and recombinant UDP-glucuronosyltransferases (UGTs). The metabolite exhibited a relatively slow rate of formation in a human liver microsome mix of 75.4 pmol/(min/mg). Further investigation identified multiple UGT isoforms to be responsible for catalyzing the addition of glucuronic acid to ethanol, with UGT1A1 and 2B7 being the two most prevalent isoforms. Co-incubation with bilirubin or 3'-azido-3'-deoxythymidine (UGT1A1 and 2B7 inhibitors, respectively) inhibited the greatest amount of ethyl glucuronide formation, though other UGT inhibitors also showed some effect. Enzyme kinetics were performed in human liver microsomes and recombinant UGT enzymes. The apparent Km (Km app) and Vmax values were determined to be 0.17+/-0.08 mM and 75.98+/-5.63 pmol/(min/mg) (human liver microsomes), 0.03+/-0.01 mM and 25.22+/-3.45 pmol/(min/mg) (UGT1A1), and 0.11+/-0.04 mM and 52.03+/-9.8 pmol/(min/mg) (UGT2B7). Thus, it appears that multiple UGTs are responsible for the formation of ethyl glucuronide and that any functional differences in the enzymology underlying ethyl glucuronide formation would most likely be masked by a combination of other enzymatic pathways.
Foti
Robert S
RS
ADME Technology Group (Drug Metabolism/Drug Interactions Laboratory), Pfizer Global Research and Development, Pfizer Inc., Eastern Point Road, Groton, CT 06340, USA.
Fisher
Michael B
MB
D000428:Alcohol Drinking / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D005554:Forensic Medicine; D005965:Glucuronates / Q000493:pharmacokinetics*; D014453:Glucuronosyltransferase / Q000493:pharmacokinetics*; D006801:Humans; D066298:In Vitro Techniques; D007527:Isoenzymes; D008099:Liver; D013058:Mass Spectrometry; D008862:Microsomes, Liver / Q000378:metabolism*; D011994:Recombinant Proteins / Q000493:pharmacokinetics*
D015415:Biomarkers; D005965:Glucuronates; D007527:Isoenzymes; D011994:Recombinant Proteins; C093924:ethyl glucuronide; D014453:Glucuronosyltransferase